![Nils Lonberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nils Lonberg
Director/Board Member at
Synthekine, Inc.
Net worth: 558 077 $ as of 2026-09-29
Profile
Nils Lonberg is currently Director-Molecular Biology at GenPharm International LLC since 1990 and Independent Director at Synthekine, Inc. Former roles include Chairman at Bicara Therapeutics, Inc. from 2023 to 2024, Senior Vice President & Scientific Director at Medarex, Inc., Member at Memorial Sloan Kettering Cancer Center, and Vice President-Oncology Discovery Biology at Bristol Myers Squibb Co. from 2009 to 2019.
Education includes a doctorate from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-14 | 29,988 ( 0.05% ) | 558 077 $ | 2026-09-29 |
Nils Lonberg active positions
| Companies | Position | Start |
|---|---|---|
GenPharm International LLC
 GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Corporate Officer/Principal | 1989-12-31 |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered cytokine therapeutics | Director/Board Member | - |
Former positions of Nils Lonberg
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2019-03-31 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
| BICARA THERAPEUTICS INC. | Chairman | 2024-07-31 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Chief Tech/Sci/R&D Officer | - |
Education of Nils Lonberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered cytokine therapeutics | Health Technology |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
- Stock Market
- Insiders
- Nils Lonberg
